Trial
NCT01408069
Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
EMS
Collaborators
—
Condition
Tensional-type Headache
Intervention
MIGRANE
Why stopped
Study canceled by decision strategically.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-24